Cargando…

Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria

Farnesylated prelamin A is a processing intermediate produced in the lamin A maturation pathway. Accumulation of a truncated farnesylated prelamin A form, called progerin, is a hallmark of the severe premature ageing syndrome, Hutchinson-Gilford progeria. Progerin elicits toxic effects in cells, lea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cenni, V., Capanni, C., Columbaro, M., Ortolani, M., D'Apice, M.R., Novelli, G., Fini, M., Marmiroli, S., Scarano, E., Maraldi, N.M., Squarzoni, S., Prencipe, S., Lattanzi, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications 2011
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284238/ https://www.ncbi.nlm.nih.gov/pubmed/22297442 http://dx.doi.org/10.4081/ejh.2011.e36

Ejemplares similares

Erratum - Autophagic Degradation of Farnesylated Prelamin a as a Therapeutic Approach to Lamin-Linked Progeria
por: Cenni, V., et al.
Publicado: (2013)

Different prelamin A forms accumulate in human fibroblasts: a study in experimental models and progeria
por: Dominici, S., et al.
Publicado: (2009)

Rapamycin treatment of Mandibuloacral Dysplasia cells rescues localization of chromatin-associated proteins and cell cycle dynamics
por: Cenni, Vittoria, et al.
Publicado: (2014)

Altered chromatin organization and SUN2 localization in mandibuloacral dysplasia are rescued by drug treatment
por: Camozzi, Daria, et al.
Publicado: (2012)

Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment
por: Columbaro, M., et al.
Publicado: (2005)

All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype
por: Pellegrini, Camilla, et al.
Publicado: (2015)

Familial partial lipodystrophy, mandibuloacral dysplasia and restrictive dermopathy feature barrier-to-autointegration factor (BAF) nuclear redistribution
por: Capanni, Cristina, et al.
Publicado: (2012)

Barrier-to-Autointegration Factor (BAF) involvement in prelamin A-related chromatin organization changes
por: Loi, Manuela, et al.
Publicado: (2015)

Diverse lamin-dependent mechanisms interact to control chromatin dynamics: Focus on laminopathies
por: Camozzi, Daria, et al.
Publicado: (2014)

Lamins and bone disorders: current understanding and perspectives
por: Gargiuli, Chiara, et al.
Publicado: (2018)

Modulation of TGFbeta 2 levels by lamin A in U2-OS osteoblast-like cells: understanding the osteolytic process triggered by altered lamins
por: Evangelisti, Camilla, et al.
Publicado: (2015)

Autophagic Removal of Farnesylated Carboxy-Terminal Lamin Peptides
por: Lu, Xiang, et al.
Publicado: (2018)

Detection of mesenchymal stem cells senescence by prelamin A accumulation at the nuclear level
por: Bellotti, Chiara, et al.
Publicado: (2016)

Prelamin A causes progeria through cell-extrinsic mechanisms and prevents cancer invasion
por: de la Rosa, Jorge, et al.
Publicado: (2013)

Nuclear damages and oxidative stress: new perspectives for laminopathies
por: Lattanzi, G., et al.
Publicado: (2012)

Defining substrate requirements for cleavage of farnesylated prelamin A by the integral membrane zinc metalloprotease ZMPSTE24
por: Wood, Kaitlin M., et al.
Publicado: (2020)

Lamin A and Prelamin A Counteract Migration of Osteosarcoma Cells
por: Evangelisti, Camilla, et al.
Publicado: (2020)

Emerin Phosphorylation during the Early Phase of the Oxidative Stress Response Influences Emerin–BAF Interaction and BAF Nuclear Localization
por: Cenni, Vittoria, et al.
Publicado: (2020)

The role of prelamin A post-translational maturation in stress response and 53BP1 recruitment
por: Capanni, Cristina, et al.
Publicado: (2022)

Potential therapeutic effects of the MTOR inhibitors for preventing ageing and progeria‐related disorders
por: Evangelisti, Camilla, et al.
Publicado: (2016)

Genomic Instability and DNA Damage Responses in Progeria Arising from Defective Maturation of Prelamin A
por: Musich, Phillip R., et al.
Publicado: (2009)

Activating the synthesis of progerin, the mutant prelamin A in Hutchinson–Gilford progeria syndrome, with antisense oligonucleotides
por: Fong, Loren G., et al.
Publicado: (2009)

Permanent farnesylation of lamin A mutants linked to progeria impairs its phosphorylation at serine 22 during interphase
por: Moiseeva, Olga, et al.
Publicado: (2016)

Nuclear Nox4 interaction with prelamin A is associated with nuclear redox control of stem cell aging
por: Casciaro, Francesca, et al.
Publicado: (2018)

Quantification of Farnesylated Progerin in Hutchinson-Gilford Progeria Patient Cells by Mass Spectrometry
por: Camafeita, Emilio, et al.
Publicado: (2022)

PCAF Involvement in Lamin A/C-HDAC2 Interplay during the Early Phase of Muscle Differentiation
por: Santi, Spartaco, et al.
Publicado: (2020)

Status of treatment strategies for Hutchinson–Gilford progeria syndrome with a focus on prelamin: A posttranslational modification
por: Chen, Xue, et al.
Publicado: (2022)

Accumulation of prelamin A compromises NF-κB-regulated B-lymphopoiesis in a progeria mouse model
por: Liu, Baohua, et al.
Publicado: (2013)

Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation
por: Blondel, S, et al.
Publicado: (2016)

Interleukin‐6 neutralization ameliorates symptoms in prematurely aged mice
por: Squarzoni, Stefano, et al.
Publicado: (2021)

Ankrd2/ARPP is a novel Akt2 specific substrate and regulates myogenic differentiation upon cellular exposure to H(2)O(2)
por: Cenni, Vittoria, et al.
Publicado: (2011)

Cell immortalization facilitates prelamin A clearance by increasing both cell proliferation and autophagic flux
por: González-Blanco, Carlos, et al.
Publicado: (2022)

The empowerment of translational research: lessons from laminopathies
por: Benedetti, Sara, et al.
Publicado: (2012)

Cutaneous and metabolic defects associated with nuclear abnormalities in a transgenic mouse model expressing R527H lamin A mutation causing mandibuloacral dysplasia type A (MADA) syndrome
por: D’Apice, Maria Rosaria, et al.
Publicado: (2020)

Case Report: An Atypical Form of Familial Partial Lipodystrophy Type 2 Due to Mutation in the Rod Domain of Lamin A/C
por: Cecchetti, Carolina, et al.
Publicado: (2021)

Ankrd2 in Mechanotransduction and Oxidative Stress Response in Skeletal Muscle: New Cues for the Pathogenesis of Muscular Laminopathies
por: Cenni, Vittoria, et al.
Publicado: (2019)

Disruption of PCNA-lamins A/C interactions by prelamin A induces DNA replication fork stalling
por: Cobb, Andrew M., et al.
Publicado: (2016)

Altered adipocyte differentiation and unbalanced autophagy in type 2 Familial Partial Lipodystrophy: an in vitro and in vivo study of adipose tissue browning
por: Pellegrini, Camilla, et al.
Publicado: (2019)

Manumycin and gliotoxin derivative KT7595 block Ras farnesylation and cell growth but do not disturb lamin farnesylation and localization in human tumour cells.
por: Nagase, T., et al.
Publicado: (1997)

Progeria
Publicado: (1935)

Cannot write session to /tmp/vufind_sessions/sess_r747phdg7kc3lnencjke58kmh5